The use of combination therapy, including the oral gonadotropin-releasing hormone receptor antagonist relugolix, estradiol, and norethindrone acetate, administered once daily, has been effective for women with uterine fibroids and heavy menstrual bleeding, while avoiding side effects associated with estrogen deficiency. Here, GNRHR is linked to uterine corpus leiomyoma.